Published in Blood Weekly, July 18th, 2002
"Monoclonal antibodies to CD20 have been used successfully in the treatment of B-cell lymphomas," explained W.K. Roberts and colleagues at the Memorial Sloan-Kettering Cancer Center in New York City. "Vaccine therapy would have the advantage of generating a polyclonal response to the antigen in contrast to the monoclonal response of an infused antibody."
The investigators inoculated Balb/c mice with a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.